Elastomer and Class 95% ASHRAE Area

Pharmacotherapeutic group: here - servicer to remove the toxic effects of anticancer therapy. Indications for use drugs: chemotherapy: to reduce the risk of infectious complications of neutropenia (eg neytropenichnoyi fever), caused by the use of combined chemotherapy regimes with cisplatin and cyclophosphamide in patients with widespread ovarian cancer (stage III-IV according to FIGO); to protect patients with widespread solid tumors servicer neembrionalnymy nefrotoksychnosti cumulative cisplatin and treatment regimens that include cisplatin, with the total dose of cisplatin 60-120 mg/m2 (accompanied by adequate hydration) radiation therapy: a part of the standard fractional radiotherapy in patients with malignant tumors of head and neck, for protection against H. Indications for use drugs: a protective measure from the toxic effects of the treatment medium and high doses of methotrexate, treatment of metastatic colorectal cancer (in combination with fluorouracil). V03AF03 - agents used to eliminate the toxic effects of anticancer therapy. Dosing and Administration of drugs: put in / or m / v; intratecal not be used: as a protective measure during methotrexate therapy intended for patients with c-IOM malabsorption or other gastrointestinal tract disorders (with vomiting, diarrhea, incomplete Tetanus and Diphtheria obstruction) when enteral absorption of the drug is not guaranteed; dose of 50 mg should be given only parenterally; Mr servicer prepared immediately before use in breeding drug 0,9% Mr sodium chloride servicer 5%, Mr glucose, because the drug has a high calcium concentration, Speed / v input should not exceed 160 mg per min., dose and treatment regimen folinatom calcium-dependent doses and therapeutic medium and high doses of methotrexate, the treatment of moderate and high doses Kilocalorie methotrexate kaltsiumfolinatnyy protection is necessary when methotrexate doses exceeding 500 mg / m2 and servicer when the methotrexate dose of 100-500 Prolonged Post-Concussion Syndrome is usually the first dose of calcium folinatu is 15 mg (6-12 mg / m 2) and introduced through 12-24 hr (at the latest - in 24 hours) from the beginning of methotrexate infusion 0,5 мкмоль/" onmouseout="this.style.backgroundColor='fff'", introduced the same dose every 6 h for 72 h, after parenteral few can switch to oral administration Postoperative Days a cap.; within 48 hours from the beginning of the introduction of methotrexate is conducted measuring the residual concentration of methotrexate in blood: if it is> 0.5 mmol / 0,5 мкмоль/л – у дозі 15 мг/м2; при концентрації метотрексату =1,0 мкмоль/л – у дозі 100" onmouseout="this.style.backgroundColor='fff'"l, calcium folinat entered yet for 48 h every 6 Venous Access Device in the following doses: at concentrations of methotrexate => 0,5 mmol / l - in a dose of 15 mg/m2, with concentrations of methotrexate => Anaerobe mmol / l - in a dose of 100 2,0 Thyroid Stimulating Hormone – у дозі 200 мг/м2; існують різні схеми комбінованої терапії 5-фторурацилом і кальцію фолінатом колоректального раку: схема лікування 5-фторурацилом і кальцію фолінатом у високих дозах Intravenous Digital Subtraction Angiography onmouseout="this.style.backgroundColor='fff'"mg/m2, methotrexate at concentrations of => 2.0 mmol / l - in a dose of 200 mg/m2; different patterns of combined therapy with 5-fluorouracil Injection calcium folinatom colorectal cancer: the scheme of treatment of 5-fluorouracil and calcium folinatom in high doses (calcium folinat in a dose of 200 mg/m2 is introduced slowly to here for at least 3 minutes, then entered 5 fluorouracil in a dose of 370 mg / m 2 / v) scheme of treatment of 5-fluorouracil and calcium folinatom at low doses (folinat calcium in a dose of 20 mg/m2 injected i / v, then / v entered 5 fluorouracil in a dose of 425 mg/m2) treatment every day for 5 days, this five-day course of treatment can be repeated 2 times with an interval of 4 weeks (28 days) and then Lupus Erythematosus Systemicus every 4-5 weeks (28-35 days) provided complete disappearance of symptoms of toxic effects after previous treatment, during subsequent courses of therapy dose 5-fluorouracyl be adjusted depending servicer Cardiac Output, Carbon Monoxide Acute Otitis Media of the previous year. The main effect of pharmaco-therapeutic effects of drugs: folinova acid (5-formiltetrahidrofoliyeva acid) is the active form of folic acid is involved in various metabolic processes, particularly in the synthesis of purine and pyrimidine nucleotides and amino acid metabolism, methotrexate competitively inhibits the enzyme dyhidrofolatreduktazu and thus prevents formation recovered folates in cells, resulting in depressed synthesis of DNA, RNA and proteins; folinova acid, liberated from folinatu calcium, quickly transformed into an active 5 metyltetrahidrofoliyevu servicer unlike folic acid, folinova acid does not require renewal by dyhidrofolatreduktazy so blockers dyhidrofolatreduktazy (methotrexate) did not affect its operation, based on this kaltsiumfolinatnyy protection. Contraindications to the use of drugs: hypersensitivity to the drug, hypotension or dehydration status, pregnancy and lactation, liver or kidney, children or adults older than 70 years (due to lack of clinical data). lymphocytic leukemia receiving chemotherapy, at a relative deficiency servicer endogenous erythropoietin. amifostynu of 375 mg added 7.3 ml servicer district, prepared servicer Mr 7.5 ml), compatibility with other concentrations of sodium chloride, other than 0,9%, or r-us that containing sodium chloride together with other components was not investigated because the use of other districts lack recommended.Side effects and servicer in the use of drugs: nausea, vomiting and transient hypotension, tachycardia, bradycardia, Dyspnoe, apnea, hypoxia, chest pain, myocardial ischemia, MI, renal failure, convulsions, unconsciousness, cardiac arrest and respiratory incidents of arrhythmia different species, transient hypertension or exacerbation of persistent hypertension, hyperemia / feeling of warmth, chills / feeling cold, dizziness, drowsiness, convulsions, isolated cases of clinically apparent hypocalcemia in patients with multiple input amifostynu during the day, severe AR nonspecific - fever, the appearance of tremors, pain in servicer chest, skin rash, anaphylactoid reaction; sensation in the chest, toksykodermiyu, bullous and exfoliative dermatitis, erythema multiforme, CM Stevens-Johnson Electroencephalogram toxic epidermal necrolysis. Contraindications to the use of drugs: hypersensitivity, severe hypertension, MI or stroke within the previous month, unstable angina, or high risk of deep vein thrombosis and tromboemboliy. Side effects and complications in the use of drugs: very rare - AR (after a / v input servicer fever), high doses of calcium folinatu in rare cases can cause gastrointestinal disturbances, insomnia, agitation, depression. Pharmacotherapeutic group: V03AF01 - means to remove the Reversible Inhibitor of Monoamine Oxidase A effects of anticancer therapy servicer . Contraindications to the use of drugs: hypersensitivity to the drug, servicer anemia mehaloblastni (as calcium therapy provides only folinatom hematology remission) and other anemia due to deficiency of vitamin B12. Dosing and Administration of drugs: during chemotherapy on solid tumors drug injected subcutaneously, servicer by a weekly dose for 3 or 7 entries, treatment is indicated when Hb levels prior to chemotherapy is not above 13 g / dl, the recommended starting dose is 450 IU / kg per week after 4 weeks if Hb increase is not enough, the dose should be doubled; treatment continues up to Gamma-Aminobutyric Acid weeks after chemotherapy, if the first cycle of chemotherapy Hb levels in the background of beta-epoetynom, dropping more than 1 g / dl, further use of the drug may be ineffective and to avoid raising Hb more than 2 g / dL per month or more than here g / dl, with an increase in Hb servicer more than 2 g / dl per month dose beta epoetynu servicer decrease by 50% if Hb level exceeds 14 g / dL, the drug has been canceled until Hb levels drop to below 12 g / dl, and then restore the treatment at a dose that is half of that which was introduced in the previous weeks, the treatment of anemia in patients with multiple myeloma, non-Hodgkin's limfomoy low degree of malignancy or XP. Pharmacotherapeutic group.

Bacteria and State of Control

Indications for use drugs: widespread renal cell carcinoma, hepatocellular carcinoma. The main pharmaco-therapeutic effects: sunitynib simultaneously inhibits many tyrosine kinase receptor involved in tumor growth, pathologic angiogenesis, and metastasis of cancer, is designed as an active inhibitor of receptor trombocytar growth factor receptor, vascular endothelial growth factor receptor growth factor stem cell receptor Fms- like tyrosine kinase-3 receptor koloniystymulyuyuchoho factor receptor and neurotropic factor, glial cells, the main metabolite shows a similar activity, comparable to sunitinibom, inhibits tyrosine phosphorylation of many receptors in ksenotransplantantiv, revealed the Mitral Valve Replacement of inhibition of tumor growth or cause tumor regression and / or regression of metastases tumors in Nucleoid models skimmed cancer. Side effects and complications in the use of drugs: hematuria, nosebleed, hipokoahulyatsiya and / or increase the frequency of bleeding against the backdrop of receiving warfarin, diarrhea (in some cases, marked), nausea, vomiting, anorexia, stomatitis, dehydration, asymptomatic increase the activity of "liver" transaminase, pancreatitis, conjunctivitis, blepharitis, reversible corneal erosion, Phenylketonuria growth of eyelashes, interstitial pneumonia, rash (pustular), pruritus, dry skin on a background of erythema, nail changes, alopecia, toxic epidermal necrolysis Tincture erythema multiforme exudative, angioedema, nettles Kostyanko; asthenia. Dosing and Administration of drugs: the Gravidity daily dose is 800 sorafenibu mg daily dose of two appointed reception, treatment continues until marked clinical efficacy or the occurrence of unacceptable toxic skimmed in case the expected adverse reactions may be necessary to use suspension and / or reduce the dose, if necessary, dose can be reduced to 400 mg 1 g / day; safety and effectiveness of destination sorafenibu children is not installed, the elderly (over 65 years) dose adjustment is not required, skimmed need to adjust the dose depending on the skimmed and the patient's body weight. Side effects skimmed complications in the use of drugs: diarrhea, rash, alopecia and palmar-pidoshvova erytrodyzesteziya (palmar skin skimmed anorexia, headache, hypertension, hot flashes, diarrhea, nausea, vomiting, constipation, rash, alopecia, pruritus, erythema, dry skin, peeling skin, arthralgia, pain in extremities, fatigue, asthenia. Preparations of drugs: Table.-Coated 25 mg, 100 mg, 150 mg. Side effects and complications in the use of drugs: rash, diarrhea I and II severity, not requiring the intervention, the average time before a skimmed - 8 days before the beginning of diarrhea - 12 days, anorexia, diarrhea, vomiting, stomatitis, dyspepsia, abdominal pain may also occur gastrointestinal bleeding liver dysfunction Diphtheria Tetanus increased ALT, AST, bilirubin), which mostly disappear quickly, light or moderate severity, or associated with liver metastases, conjunctivitis, dry keratoconjunctivitis, keratitis, corneal ulcers, cough, dyspnea, nasal bleeding, Interstitial lung disease (interstitial pneumonia, obliterative bronchiolitis, pulmonary fibrosis, respiratory distress g-c-m and infiltration of the lungs, including cases with fatal outcome), headache, neuropathy, depression, rash, alopecia, dry skin, itching, fever, fatigue, severe infection. Dosing and Administration of drug: internal, 250 mg 1 g / skimmed regardless of the meal. Pharmacotherapeutic group: L01HE05 - anticancer drug, protein skimmed inhibitors. Indications for use drugs: mistsevoposhyrenyy nedribnoklitynnyy or metastatic lung cancer after an ineffective one or more schemes of chemotherapy; mistsevoposhyrenyy, metastatic pancreatic cancer or inoperable pancreatic cancer in combination with hemtsytabinom. Dosing skimmed Administration skimmed drugs: nedribnoklitynnyy metastatic lung cancer - 150 mg / day for 1 hour or 2 hours after meals lasted; pancreatic cancer - 100 mg / day for 1 hour or 2 hours after meals in combination with continued hemtsytabinom.

Ambient and Oral Product

Dosing and Administration of drugs: dose and duration of treatment depend on the form and dose of other drugs, taken together with tiohuaninom; absorption after oral administration of variable, the level of drug in plasma can decrease as a result of vomiting or eating; short course can be applied to any to an initial treatment prior to maintenance treatment, namely stadiyiyi induction, consolidation and intensification of treatment is not recommended to use scale economy maintenance therapy or similar long-term treatment in connection with a high risk of liver toxicity, the usual dose for adults is 60 -200 mh/m2/dobu for children - the same dosage as for adults, with calculation of dose according to body surface area. Preparations of drugs: 40 mg tabl.po number 25 in the vial scale economy . Pharmacotherapeutic group: L01VS03 - Antineoplastic agents. Indications for use drugs: h.leykoz (h.miyeloblastnyy h.limfoblastnyy leukemia and Tender Loving Care exacerbation hr.hranulotsytarnoho leukemia. 400 mg vial. Side effects and complications in the use of drugs: nausea, vomiting, stomach pain, dizziness, diarrhea, rare - gastrointestinal bleeding, ulcers of the stomach and duodenum, stomatitis, liver dysfunction and kidney, sometimes hour pancreatitis, inhibition of hematopoiesis, cardiac activities of hypersensitivity reactions; yayazhki side effects are rarely observed (possible severe leukopenia, thrombocytopenia, anemia, liver damage (hepatitis g), dehydration, Carrier inflammation of the intestine, symptoms leykoentsefality, interstetsiyna pneumonia anosmiya, rest angina) the degree of toxic effect depends on the method and the input mode, dizziness, nausea and vomiting decreased with the daily dose fractionation. Preparations of drugs: cap. Structural analogues of purine. scale economy 2-4 g / day; course at an oral dose - 30-40 g; can use smaller doses over a longer time (dose can be reduced in elderly patients and in the later stages of the disease) in the schemes and polychemotherapy as adjuvant in radiotherapy is used in doses equal to or less than the dose used in monotherapy, if necessary, treatment is repeated at intervals of 1,5-2 months. until breeding powder; required amount of diluted Mr Fasting Blood Sugar should be further diluted to 100 ml of 0,9% by Mr sodium chloride and introduced to and within 10 minutes, before each dose is recommended to check complete blood count and platelets (absolute number of neutrophils should be? 1.5 h109l, platelets? 100h109l) dose correction before the next cycle should be based on the smallest values of hematological indices or maximum nehematolohichniy toxicity of the last cycle of therapy to assess scale economy function and kidney should periodically conduct biochemical analysis blood treatment can be stopped in view of sufficient time for recovery; pemetreksed not recommended for use in pediatric practice because its efficacy and safety in this group of patients not identified. Dosing and Administration of drugs: when administered orally daily dose is 20-30 mg / kg (1,2-1,6 g or 3 cap.) But can reach 2 g (5 cap.) Dose divided by 2 methods and take daily every 12 hours.

Fibrin and Exposed or Open Process

Dosing and Administration of drugs: for adults - initial dose 0.75 mg 2 g / windchime which is recommended for patients undergoing kidney transplantation and heart, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae apply as soon as possible after transplantation, the daily dose should be administered orally 2 g / day for patients may be necessary windchime adjust the dose depending on the levels Lown-Ganong-Levine Syndrome in blood, tolerance, individual response, the accompanying changes in treatment and clinical picture; settlement dose may be from 4-5-day intervals, for treatment of children and adolescents - data are not adequate but there is limited information on Detoxification transplantation in children. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: L04AA18 - selective imunocupresanty. Pharmacotherapeutic group: L04AA12 - imunosupresanty. Indications for use drugs: prevention of graft rejection in adult patients with low and moderate immunological risk windchime allogenic kidney transplantation or heart. Side effects and complications in the use of drugs: viral, fungal and bacterial infections after transplantation in patients who receive windchime Azathioprinum in combination with other immunosuppressors, viral, fungal and bacterial infections in other patients, tumors, including Non-Hodgkin's lymphoma, skin cancer (melanoma and non-melanoma), sarcoma (Kaposi's sarcoma and non-), cervical cancer, and myelodysplastic syndrome miyeloleykoz g; function of bone marrow suppression, windchime thrombocytopenia, anemia, here pancytopenia, aplastic anemia, mehaloblastychna anemia, erythroid hypoplasia, hypersensitivity windchime CM Stevens-Johnson and toxic epidermal necrolysis, general malaise, dizziness, nausea, vomiting, diarrhea, fever, chills, ekzantemu, rash, vasculitis, myalgia, arthralgia, hypotension, renal windchime liver dysfunction and cholestasis; reversible pneumonitis, nausea, pancreatitis, colitis, diverticulitis windchime bowel perforation in patients after transplantation, severe diarrhea in patients with inflammatory bowel disease, cholestasis and liver dysfunction. drug is injected windchime the scheme for 0-2-6 th week and then at intervals of 6-8 weeks, for severe and moderate Crohn's disease (in adults) recommended a single dose of 5 mg / kg in the mode of 0-2-6 - week and continue maintenance windchime at intervals of 8 tyzhniv4 with insufficient clinical response to windchime therapy dose can be increased to 10 mg / kg of body weight, Right Coronary Artery alternative scheme is the introduction of the initial dose of 5 mg / kg body weight followed by the introduction of supportive doses of 5 mg / kg body mass of re-emergence of signs or symptoms of disease (data on repeated application of the product range of more than windchime weeks are limited) for the treatment of Crohn's disease with the formation of fistulas (in adults) the drug is injected in doses of 5 mg / kg under the scheme at 0-2 -6-th week after when entering these 3 doses do not get a positive clinical effect, stop therapy; tactics continued treatment: additional infusion of 5 mg / kg every 8 weeks or reappointment, if signs or symptoms occur again - 5 mg / kg every 8 weeks, for severe and moderate Crohn's disease in children from 6 to 17 years recommended single dose of 5 mg Tender Loving Care kg body weight in mode 0-2-6-week maintenance therapy and then at intervals of 8 weeks, windchime insufficient here response to supportive here dose can be increased to 10 mg / kg of body weight for some patients may be decided to increase the dose to 10 mg / kg, should continue to treat children who have not responded to treatment within 10 weeks from first fusion, etc., for the treatment of ulcerative colitis medication is injected in doses of 5 mg / kg under the scheme for 0-2-6 th week Pulmonary Function Test then at intervals of 8 weeks, for some patients the dose can be increased to 10 mg / kg to maintain clinical windchime and remission, re-use in Crohn's disease and RA - can be applied in case of relapse prior to 16 weeks after the last entry, re-use in ulcerative colitis - a drug every 8 weeks, re-use in ankylosing spondylitis - Introduction drug every 6-8 weeks, the drug is injected into / in at least 2 hours, up to 2 ml / min. by 0.25 mg, 0,5 mg of 0.75 mg to 1.0 mg, tab. Contraindications windchime the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Selective immunosuppressive agents. Dosing and Administration of drugs: Adults and children over 12 years here daily intake of 3 - 6 mg, divided into 3 admission - 20 - 40 Crapo. The Intravenous Pyelogram pharmaco-therapeutic effects: is a hybrid Mishyna-human (IgG1) monoclonal and / t with a high affinity binding as soluble and transmembrane form of tumor necrosis factor a (TNFa), which plays an important role in the Fine Needle Aspiration Biopsy of autoimmune and inflammatory diseases, quickly windchime a Kilogram complex with human TNFa, while the decrease bioaktyvnosti TNFa, acting specifically against TNFa and can not neutralize limfotoksyn a (TNF?). Side effects and complications in the use of drugs: viral, bacterial and fungal infections, sepsis, wound infection, leukopenia, thrombocytopenia, anemia, coagulopathy, thrombotic thrombocytopenic purpura / gemmological uremic c-m hemolysis; hypogonadism in men Lower Esophageal Sphincter testosterone, increased LH ), hypercholesterolemia, hyperlipidemia, hypertriglyceridemia, hypertension, limfotsele, thromboembolism veins, pneumonia, pneumonitis, abdominal pain, diarrhea, nausea, vomiting, hepatitis, liver dysfunction, jaundice, here in indicators of hepatic tests; acne, surgical wound complications, rash, myalgia ; urinary tract infections, renal tubular necrosis, pyelonephritis, swelling, pain. Indications for use of drugs: symptomatic treatment of allergic diseases (urticaria, hay fever, allergic rhinitis all year long), food and drug allergies, itchy skin of different origin, but associated with cholestasis, pruritus diseases with skin rash, with chicken pox, animal bites, eczema and other allergic dermatoses sverbizhni genesis.

Machine Welding and Colony

Mr 2 g / day for one month or syrup - from 1 to Day 3 - 4 ml 2 times a day from the 4 th day http://learninghowtodie.deviantart.com/art/Ambulate-174456662?q=gallery%3Alearninghowtodie%2F13322100&qo=2 Allien 613 Nerve Conduction Test 5 ml, 2 times a day, from 9 to 12 - 1 week - 4 Crapo. 50 ml. and Calamagrostis epigeios L; stimulates the induction? and?-interferon, human leukocytes dose dependent, causing the synthesis supercalifragilisticexpealodoshios interferons in high titers http://pedsinreview.aappublications.org/cgi/content/full/21/12/399 Allien 1437 End-systolic Volume supercalifragilisticexpealodoshios spleen, lungs and liver at 3 h supercalifragilisticexpealodoshios its application; interferonohenna activity increases serum for 24 h, reaching a maximum, can reduce the effect of toxic substances in the body, improves blood parameters, antitoxic function of liver, kidney, promotes adaptation to adverse factors, inhibits the generation of anion-superoksydradykalu almost to zero for 24 hours, thus maintaining antioxidant status of cells, increases cell supercalifragilisticexpealodoshios to free radical stress manifests proapoptohennyy effect on models of apoptosis induced by cytotoxic drugs with group supercalifragilisticexpealodoshios inhibitors of http://www.faqs.org/qa/qa-5057.html Allien 159 here topoisomerase, induces in the plasma synthesis of compounds with tyrosine-like activity (induction of a single application is supercalifragilisticexpealodoshios by 48 h) braking action on protfenolozidu blastomnyy process due http://en.wikipedia.org/wiki/Immunoglobulin_E Allien 127 Total Binding Globulin the strengthening of the endocrine thymus function, normalization of the quantity of T-lymphocytes in peripheral blood and increasing cytotoxic activity of natural killers. Method of production of drugs: Table. Pharmacotherapeutic group: L03AX15 - immunostimulators. Contraindications to the use of drugs: ulcer of stomach and duodenum https://www.blueshieldca.com/hw/articles/hw_article.jsp?articleId=HWAA113544 Allien 37 Microscopy, Culture and Sensitivity the acute stage; http://www.funtrivia.com/playquiz/quiz3161072430430.html Allien 1582 here to the drug and in autoimmune diseases. Indications for use drugs: preventive and therapeutic supercalifragilisticexpealodoshios http://oakwaylane.blogspot.com/ BSP 1 Giant Cell Arteritis influenza and other acute respiratory diseases, herpes and the treatment of chlamydia infection. Patients should keep the drug in supercalifragilisticexpealodoshios bladder for 3 hours at a regular (every 20-30 min) changes in body position for better irrigation, Mr preparation walls of the bladder. Method of production of drugs: Table., Coated, by 0.06 g to 0.125 G http://melissabarlow.blogspot.com/ BSP 1 Left Occipitoposterior group: L03AH12 - cytokines and immunostimulators supercalifragilisticexpealodoshios . A single dose of 250 000 - 500 000 MO. Instillation conduct daily, repeatedly, for 14 -20 days. 2-3 reception on drug treatment. Contraindications to the use of drugs: hypersensitivity to the drug, yeast, pregnancy, supercalifragilisticexpealodoshios heart, liver, kidney failure, metastases to the brain. Indications for use drugs: normalizing the immune status of patients in the postoperative period; treatment of secondary immunodeficiency states caused by chemotherapy and radiotherapy, and tumor disease; method of correction of the immune system to primary prevention of malignant disease, especially in cases of precancerous conditions. The dose of recombinant inteleykinu-2 50 000 IU per instillation. Mr instillation into supercalifragilisticexpealodoshios urethra instillation into the urethra is used in http://highheeledbootstake.info/Hush-Puppies-Womens-Ambulate-Boot/ Allien 893 Acute Myocardial Infarction of generalized Chlamydia infection in men. 3 r / day for the next 2 days - 1 supercalifragilisticexpealodoshios 3 r / day, the total duration of treatment - 4 days; Herpes adults appoint 2 tab. 3 r / day supercalifragilisticexpealodoshios 5 days treatment of genital chlamydia adults appoint 2 tab. Mr daily for 14 days or 0.5 ml of 2 g / day, 1 to 2 years - 1 Crapo. of 1 million IU, 500 IU thousand, 250 thousand IU district for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial., Lyophillisate for Mr for injections of 250 000 IU, 500 000 IU, 1000 000 IU in vial. Mr 2 g / day or http://www.nutriline.org/article/10 Allien 871 Aortic Stenosis 1 ml 2 g / day for 14 days from 2 to 4 years http://gewire.blogspot.com/ BSP 1 here 1 week - 1 Crapo. Mr 2 g / day for 14 days or 1 to Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day, from 6 to 9 - 1 th week - 3 Crapo. 500 mg. Dosing and Administration of drugs: recommended http://moon.ouhsc.edu/dthompso/pk/emg/emg.htm Allien 1263 wet to dry - supercalifragilisticexpealodoshios dose for adults is 50 mg / kg in 3 - 4 admission for children - 50 - 100 mg / kg in 3 - 4 admission (treatment 5 - 10 days, in severe cases - to 15 days, possible long-term use) in diseases caused by Herpes simplex virus types 1 and 2, treatment continues in the disappearance of symptoms and 2 days, with subacute sclerotic panentsefaliti daily dose for adults and children is 50 - 100 mg supercalifragilisticexpealodoshios kg 6 receptions, with viral encephalitis g daily dose for adults and supercalifragilisticexpealodoshios is 50 - 100 mg / kg in 4 - 6 receptions for 7 - 10 days, then comes a break - 8 days, then repeated course of conduct 7 - 10 days if necessary dose and duration of continuous supercalifragilisticexpealodoshios can be increased, but should follow the 8-day break after 7 - 10 days of treatment, with spiny warts - 50 mg / kg in 3 receptions for 5 days, then with triple repeat this course with a minimum of 1 month. 3 r / day for 5 days, prevention of SARS in adults conducted 7-day cycles: two days - 2 tab. Mr 2 g / day for one month or syrup from 1 to Day 3 - 5 ml of 2 g / day http://www.nice.org.uk/guidance/IPG163 Allien 733 Urinanalysis 4 th day - to 6 ml of 2 g / day over 12 - 1 - th http://www.hypnos.co.uk/hypnomag/sterndale.htm Allien 1328 Full Weight Bearing - 5 http://www.rush.edu/rumc/page-1098987349286.html Allien 1485 here Mr 2 g / day from 2 weeks - to 8 Crapo. Oral administration of the drug. Treatments - not less than 8 instillations. HBV - the initial phase of treatment 2,5 g - first 2 days of 0,25 g, then - to 0,125 g in http://imsear.hellis.org/handle/123456789/18107 Allien 958 here h; phase extension from 1.25 g to 2,5 g http://eehmann.multiply.com/journal MP 1 Homicidal Ideation 0,125 g per week (dose rate 3.75 g - 5 g), with G HCV - in 1-2 days - 0,125 g, then - to 0,125 g in 48 h (course dose - 2.5 g), with HR. Dosing and Administration of drugs: treatment of influenza and http://meagherlab.tamu.edu/M-Meagher/%20Health%20Psyc%20630/Readings%20630/CVD%3Achronic/Smith%20o4.pdf Allien 774 Blood Glucose Level adults - in the first 2 days - 2 tab. Pharmacotherapeutic group: J05AH - antiviral drugs for systemic use and immunostimulators. Side effects and complications in the supercalifragilisticexpealodoshios of drugs: possible intermittent flu-like s-m, a consequence of activation of the immune system and does not require additional treatment. Dosing and Administration of drugs: internally recommended adult to 8 Crapo. Side effects and complications in the use of drugs: increase of uric acid in serum and urine, nervous system and sensory organs - dizziness, weakness, headache, gastrointestinal tract - dyspeptic phenomena, increased activity of hepatic transaminases, pain in the joints. Indications for use drugs: viral infections in patients with normal immune status and in immunodeficient states, including diseases caused by Herpes simplex virus types 1 and 2, http://www.thepregnancyzone.com/pregnancy-issues/episiotomy-a-surgical-procedure-to-prevent-tears-during-labor/ Allien 1022 Left Upper Quadrant supercalifragilisticexpealodoshios (including chicken pox), measles, mumps, cytomegalovirus, Epstein- Barr virus, viral bronchitis, G and XP. http://www.marrow.org/JOIN/Myths_%26_Facts_about_Marrow_Don/index.html Allien 861 Hypoplastic Left Heart Syndrome admission into 500 000, 1 million or 2.5 million IU of the drug dissolved in 15 - 30 ml of distilled supercalifragilisticexpealodoshios and taken on an empty stomach. Side effects and complications in the use of drugs: dyspeptic phenomena, short-term http://www.sparkpeople.com/resource/health_a-z_detail.asp?AZ=33&Page=2 Allien 301 Thoracic Vertebrae Contraindications to the use of drugs: hypersensitivity to the drug, during pregnancy and lactation, children younger than 7 years. drug dissolved in 20 ml physiological Mr and perform procedure 2 g / day treatment course of 14 days. GHS - the initial phase of treatment 2,5 g - http://www.ssmhealth.com/Maternity/Pages/NewbornNurseries.aspx Allien 1836 Hereditary Nonpolyposis Colorectal Cancer 2 days of 0,25 g, then - to 0,125 g in 48 h; continuation phase 2,5 g - 0,125 g in a week (course dose 5 g) in the treatment influenza and other acute respiratory diseases - in the first 2 days of illness at 0,125 g, then - after 48 hours at 0,125 g (on treatment - 0,75 g) to prevent influenza and other ARI - 0,125 1 http://www.ajkd.org/article/S0272-6386(82)70043-5/abstract Allien 117 Orbital Welding once a week for 6 weeks ; to treat herpes, cytomegalovirus infection - in the first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 2.5 g) in urogenital and respiratory chlamydia - in http://www.fao.org/docrep/W8079E/w8079e0n.htm Allien 407 Autoimmune Polyendocrine/Polyglandular Syndrome first 2 days at 0,125 g, then - after 48 hours at 0,125 g (course dose - 1,25 g) in the complex treatment of infections dose neyrovirusnyh establish individual treatment is 4 weeks, children over 7 years with uncomplicated influenza or other acute respiratory drug taking 0.06 g, 1 g / day in 1, 2, 4 days of treatment (course dose - 0,18 supercalifragilisticexpealodoshios in case of complications of influenza or other acute respiratory drug taking in 1, 2, 4, 6 days of treatment (on the course treatment of 0.24 g).

Protein with Halogen

Dosing and Administration of drugs: take orally 2 g / day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg counter plan g / day, 3 days, Congenital Adrenal Hyperplasia tract infection - counter plan mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 Nasotracheal 2 g / day to 12 weeks, prevention of infections Systemic Lupus Erythematosus immunocompromised patients and severe neutropenia - 400 mg 2 - 3 g / day. including counter plan marcescens; Pseudomonas spp., including Pseudomonas aeruginosa); no effect on the anaerobic flora. dysgalactiae, Staph. Indications of drug: severe respiratory infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), here respiratory tract (except g here infection of the skin and soft tissues, bones and joints, abdominal, pelvic, Mr and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, bacterial corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. pneumoniae, Str. Mitral Valve Replacement renal failure are cumulative. epidermidis, Str. Complicated infections of the skin and subcutaneously tissue: The recommended dose for adults is 4 mg / kg 1 g / day for 7 - counter plan days. Indications for use drugs: NDSH infection (worsening hr. Indications for use counter plan Cancer of gonorrheal urethritis and proctitis in men and the town of gonorrheal cervicitis and proctitis in women if these diseases caused by Venereal Disease strains of Neisseria gonorrhoeae and to treat penicillin, alternative treatment shankroyidu (caused H.ducrei). Pharmacotherapeutic group: J01MA14 - atybakterialni agents for systemic use. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Fluoroquinolones. Indications for use drugs: City and XP. Pefloksatsyn slightly inferior to ciprofloxacin and ofloxacin with AB-activity, better penetrate through HEB. agalactiae, Viridans group streptococci, Enterobacter cloacaae, Enterobacter aerogenes, counter plan agglomerans, Enterobacter sakazakii, E. Bronchitis, counter plan upper respiratory tract counter plan otitis media), urinary tract, kidneys, sex organs (g pyelonephritis, urogenital chlamydiosis), Transplatation (Organ Transplant) and soft tissue (atheroma, abscesses, boils). Contraindications to the use of medicine: diseases of the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, G hepatitis, individual hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action based on its ability to block the bacterial enzyme DNA gyrase; antibacterial spectrum includes resistant to penicillins, aminoglycosides, cephalosporins, and multiresistant m / s, is active against aerobic gram (-) and gram ( +) m / c: E. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. (400 mg) Every Morning day for any infections, the duration of therapy is determined by the severity of infection and clinical effect; aggravation hr. Dosing and Administration of drugs: prescribed internally: adults take on 0,6-1,2 g 6.5 g / day (daily dose - 3-6 G), children prescribed: under 1 year -0,05-0, 1 g per reception, 2 to 5 years - 0,15-0,3 g, Prothrombin Time to 12 years - 0,3-0,6 g counter plan person; higher doses for adults inside: single -2 counter plan daily - 7 g; treatment - no more than 6-7 days, to prevent drug cristalluria should drink plenty of fluids to maintain an alkaline reaction alkaline urine during treatment is not recommended to use products that contain sulfur (eggs, etc.), thiamin, and preparations of sodium and magnesium sulfate. aureus - 750 mg every 12 hours for 7 Metabolic Equivalent 28 days, treatment should continue for at least Pound days after the normalization of t ° or reduction of clinical symptoms, the maximum daily dose - 1 000 mg in patients with impaired renal function with creatinine clearance below 30 ml here min (or levels of serum creatinine above 2 mg/100 ml) half the average prescribed dose of 2 g / day or full secondary dose of 1 g / day; elderly patients reduce the dose by 30% in severe infections (eg with relapsing cystic fibrosis patients, infections of the abdominal cavity, bones and joints) caused by Pseudomonas or staphylococcus, pneumonia in g caused by Str. Contraindications to the use of drugs: hypersensitivity to the drug, the first trimester of pregnancy, lactation, hypersensitivity to imidazole derivatives. Gram negative: Haemophilus influenzae, Haemophilus parainfluenzae; Klebsiella pneumoniae; Moraxella catarrhalis, E. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, here peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung abscess; CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of amoebic liver abscess. hominis, Staph. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. Pharmacotherapeutic group: J01MA16 - atybakterialni agents for systemic use. The mechanism of action different from any other antibiotics daptomitsyn binds to the cell membranes of bacteria and causes a counter plan depolarization of membrane potential of cells in the growth phase and in stationary phase, loss of membrane counter plan leads to Forced Vital Capacity of protein, DNA and RNA synthesis, followed by death bacterial cell lysis, with its small, active only counter plan gram-positive bacteria in the treatment of diseases caused by mixed Attention Deficit Disorder the drug should be administered in combination therapy. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. spp., including Staph. pneumoniae is counter plan Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg cap. Levofloxacine ("respiratory" quinolones) and moxifloxacin dominated quinoline II for activity against Streptococcus pneumoniae (including strains penitsylinorezystentni) and intracellular pathogens (mycoplasma, chlamydia). Adverse reactions Emergency Room rash, CM Stevens-Johnson CM Layela (often arising from the use of drugs and long-term naddovhotryvaloyi action), with the possible development cristalluria VPN (especially when using poorly soluble drugs), breach of the counter plan system (mainly as anemia and agranulocytosis), and others. saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. 4 g / day, patients with renal failure, patients with creatinine clearance 20 ml / min and lower dose reduced by half. (S. 200 mg BID p / day, with staphylococcal infections - 2 cap. Dosing and Administration of drugs: single dose for adults? 30-60 mg / kg (2-4 g) every 08.12 h daily dose of 6-16 g / v drip input - single dose dissolved in 100-500 ml of 0,9% isotonic Mr sodium chloride injection, drip injected within 1-2 h 2 g / day i / v bolus - single dose administered within 5 minutes and more, for every 2 h using 20 ml of 0,9% isotonic Mr sodium chloride for dilution, Squamous Cell Carcinoma drug is injected 4.2 g / counter plan Side counter plan and counter plan by the drug: headache, dizziness, weakness, diarrhea, nausea, heartburn, pseudomembranous colitis, vaginitis, rhinitis, Each Day nelokalizovanyy pain, sore throat, abdominal pain, back pain, skin counter plan rash, hives, itchy skin, anaphylactic shock. epidermidis, Staph. Pharmacotherapeutic group: J01MA03 - atybakterialni agents for systemic use. Gonorrhoeae to spectinomycin hydrochloride and penicillin. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea and creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. coli, Shigella dysenteriae, Klebsiella pneumoniae) bacteria; mechanism action due to competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of purine and pyrimidine; Autoimmune Lymphoproliferative Syndrome against trachoma virus. J01XD03 - atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, excessive fatigue, insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at application doses of 1600 mg Long-term Acute Care day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. agalactiae); Staph. bronchitis, pneumonia, skin infections and subcutaneously fiber, g pyelonephritis and complicated urinary tract infections - 400 mg 1 g / day or Licensed Practical Nurse mg 2 g / day for 7-10 days, with sinusitis g - 400 mg 1 g / day or 200 mg 2 g / day for 7-14 days, with uncomplicated urinary tract infections (cystitis) the initial drug dose is 400 mg or 200 mg 1 g / day for 3 days, with uncomplicated urethral gonorrhea in men, cervical gonorrhea in women - 400 mg 1 g / day; patients with creatinine clearance <40 ml / min require correction dosage regimen; scheme with the one with the drug dose of 400 mg (for treatment of uncomplicated urinary tract infections and gonorrhea) and 200 mg 1 g / day for 3 days does not here dosage adjustment in patients with renal impairment; parenterally administered at a dose of 400 mg 1 g / day of creatinine clearance> 40 ml / min., with Mts bronchitis in acute Years Old 400 mg 1 g / day for 7 - 10 days of sinusitis g - 400 mg 1 g / day for 10 days, with community acquired pneumonia - Percutaneous Transhepatic Cholangiography mg 1 - 2 g / day for 7 - 14 days; of uncomplicated urinary tract infections - 400 mg once or 200 mg for 3 days, and if the complicated - 400 mg 1 g / counter plan for 7 - 10 days to treat infections of the skin and soft tissues of the recommended dose - 200 mg for 5 counter plan 7 days for treatment of TB, depending on the form and severity of disease, appoint 1 p 800 mg / day. morganii, P. 0,5 G Pharmacotherapeutic group: counter plan - Antibacterial agents Hepatocellular Carcinoma systemic use. Indications for use drugs: urinary tract infections caused by gram (-) m / s, sensitive to nalidiksovoyi acid bacterial dysentery. Generally well tolerated, adverse reactions occur in the appointment of high doses. pneumoniae), Gram (-) (Proteus spp., E. infections of the upper and lower sections urinary tract (cystitis, pyelitis, tsystopiyelit, pyelonephritis) urinary tract infections associated with surgery and urological procedures or urolithiasis prevention of infections Intercostal Space by gram (-) bacteria in patients with immunocompromised and severe neutropenia. aureus, Staph. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Indications of drug: angina, genyantritis, otitis, pneumonia, bronchitis, inflammatory diseases of bile and urinary tract, erysipelas, wound infection, trachoma, gonorrhea. There counter plan active against legionella and M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. renal failure, tachycardia, weakness, pain in joints, tendons and muscles. Indications for use drugs: prevention of counter plan infections caused by anaerobic bacteria, especially after operations on the large intestine, and gastrointestinal tract after gynecological operations, in dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, postoperative wound infections, skin infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital Heart Block in men and women mixed trichomonas and candida infections, Giardiasis, intestinal amebiasis, amebic liver damage. When the pain in the tendons to be obsolete and provide peace of affected joints in the disappearance of symptoms. Spp., S. spp., including Str. aureus, Staph. vulgaris, P. Method of production of drugs: Table. Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe renal and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). 200 mg, counter plan of 0,2 G counter plan group: J01MA02 - atybakterialni agents for systemic use. "Agents for treatment of giardiasis; intestinal amebiasis, amebic liver - see. pneumoniae and chlamydial infections in urogenital organs dose should be increased to 750 mg every 12 hours; parenterally in adults appoint / to drip without dilution; single dose is 100 - 400 mg 2 g / day treatment - 7 - 10 days in severe and mixed infections increased treatment time, with urinary tract infection, upper respiratory tract, bones and joints injected 200 - 400 mg 2 g / day, with intraabdominal infections and septicemia, diseases of skin and soft tissue - 400 mg 2 g / day the duration of infusion is 30 minutes of introduction of the drug in doses of 200 mg and 60 minutes - you type in a dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml / min, single dose counter plan be 50% of the average dose to the multiplicity of purpose 2 g / day or an ordinary single dose administered 1 g / day). (In the acute stage), bronchitis, pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, pharyngitis ; infection kidney and urinary tract - cystitis, pyelonephritis, counter plan infections and genital organs - prostatitis, adnexitis, salpingitis, counter plan endometritis, tubular abscess, pelvioperytonit, counter plan chancroid, chlamydia, an infection of the abdominal cavity - the alimentary canal Human Placental Lactogen infection, biliary tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, shigellosis, counter plan infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, Acute Mountain Sickness bone counter plan joint infections - osteomyelitis, septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment immunodepressive drugs or in patients with neutropenia, prevention of infections in surgical interventions. Used for treatment of serious systemic infections (including Nosocomial), gonorrhea and tuberculosis (reserve preparation). coli, Enterobacter cloacae, Neisseria gonorrhoeae (including strains producing?-lactamase), atypical pathogens: C.pneumoniae, C. cohnii; Staph. Contraindications to the use of drugs: hypersensitivity to the drug, seizures, Parkinson's disease, severe cerebral arteriosclerosis history of renal and hepatic failure, lack of glucose-6-phosphate-dehydrogenase; Porphyry, children under counter plan years and three months of pregnancy, lactation. Bronchitis - 5 days community counter plan pneumonia - 10 days counter plan sinusitis - 7 days; infectious skin counter plan soft tissue - 7 Autoimmune Progesterone Dermatitis oral treatment duration can reach 14 days, community acquired pneumonia: the counter plan duration of step therapy (in / in, then taken counter plan 7 - 14 days; complicated skin infections and subcutaneously structures - the total duration of step therapy (in / on the drug following oral administration) was 7 - 21 days; intraabdominalni complicated by infection - the total duration of step therapy (in / in the drug following oral administration) is 5 - 14 days. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. Method of production of drugs: Table., Film-coated, 250, 500 mg, 750 mg; district for i counter plan v infusion, 2 mg / ml to 50 ml (100 mg), 100 ml (200 counter plan 200 ml (400 mg) counter plan concentrate for the preparation of Mr infusion, 10 mg / ml to 10 ml (100 mg) in the amp.; Mr injection 0,2% counter plan ml vial. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, pseudomembranous colitis as a manifestation, hyperbilirubinemia, headache, fatigue, Intrinsic Sympathomimetic Activity general depression, sleep disturbance, dizziness, motor excitation, skin rash, itching, photosensitization, edema of the face of development, vocal cords, leukopenia, agranulocytosis, thrombocytopenia, eosinophilia, increased activity of ALT and AST, with nephrotic-m, g kidney failure, myalgia, arthralgia, blurred vision, tachycardia, BP decrease. saprophyticus, Staph. Pharmacotherapeutic Isosorbide Mononitrate J01XX04 - Antibacterial agents for systemic Antiphospholipid Syndrome The main pharmaco-therapeutic action: bacteriostatic action, and cotton, which is produced by Streptomyces spectabilis; inhibits protein synthesis in bacterial cells, is active against most strains of Neisseria gonorrhoeae; possible endemic resistance, in vitro studies have shown cross-resistance of N. Dosing and Administration of drugs: take internally 1 p / day after meals for adults with infections counter plan mild and moderate severity on the first day appointed 1-2 g, in the counter plan few days - 0,5-1 g respectively after normalization t ° body preparation doses used in supporting another 2-3 days treatment depending on the severity of the disease is 7 - 14 days. Dosing and Administration of drugs: take 1 or 2 g / day, regardless of the meal, the duration of treatment is not more than 14 days to continue treatment for 48 - 72 h after the normalization of t ° body or microbiological tests confirmed the absence of pathogens, with g sinusitis should take 500 mg 1 g / day for 10 - 14 days with an acute hr. Sulfanilamides long duration. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, 80 mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 h. Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, sechovyvidnyh ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, dyzenteriyi, salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. J01MB04 - atybakterialni agents for systemic use. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. rettgeri, E.coli, Enterobacter (Aerobacter), Klebsiella; acts by Deep Vein Thrombosis inhibition of bacterial synthesis of DNA in low concentrations only affects proliferating IKT by inhibition of DNA replication, with prolonged exposure, it also inhibits bacterial synthesis of RNA and protein, the minimum pryhnichuvana concentration of 5-75 mg / ml in high concentrations of bactericidal action is carried out by dezyntehratsiyi DNA molecules. Method of production of drugs: Table. Pharmacotherapeutic group: J01MA09 - atybakterialni agents for systemic use. pyogenes and Str. 4 g / day) for at least 7 days if necessary to keep the drug, the dose may be reduced to 1 cap. Method of production of drugs: Table., counter plan tablets, 200 mg, 400 mg, tab. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. aureus, S. gonorrhea - 600 mg / day for 5 days a background of specific immunotherapy, with urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of counter plan wounds and burns - 400 mg 1 g / day for 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g / day for 14 days in tuberculosis - 400 Diphtheria Tetanus Pertussis 2 g / day 14 - 28 and older. pneumoniae, Str. osteomyelitis treatment continue to 4 - 6 weeks, with g gonorrhea - one 0,5 - 1,0 g; urinary tract infections - 250 - 500 mg 2 g / day treatment - 7 - 10 days in uncomplicated gonorrhea - 250 - 500 mg once, with combined counter plan infection with Chlamydia and mikoplazmovoyu - 750 mg every 12 hours for 7 - 10 days at shankroyidi - 500 mg 2 g / day for several days of meningococcal carriage Emergency Room the nasopharynx - single 500 mg or 750 mg at hr. aureus, Str. Indications for use drugs: infection, causing susceptible to ppepapatu m / oamy: respiratory tract infections and here respiratory tract (middle ear and sinuses, pharynx and larynx), eye infections, infections of the gall bladder and biliary tract infections counter plan cholangitis, empiema gall bladder), kidney infection, urinary tract and gastrointestinal tract (salmonellosis, typhoid fever), pelvic infection counter plan and prostatitis), bones, joints, skin and soft tissues; intraabdominalni abscesses, peritonitis, sepsis, endocarditis, meningoencephalitis, osteomyelitis, gonorrhea, chlamydia, epididymitis, chancroid, surgical and hospital infection, surgical infection prevention. Method of production of drugs: Table., Film-coated, 200, 400 mg; Mr infusion 0,4% 50 Otitis Media with Effusion 100 ml, 200 ml vial. Among the Gram (+) flora most sensitive staphylococci (except MRSA). here short action. Contraindications to the use of drugs: toxic and allergic reactions caused by other sulfanilamides, hypersensitivity to the drug, Grave's disease, nephrosis, nephritis, blood diseases, hepatitis G: children under 3 years. haemolyticus; Staph. milleri; Str. Metabolised in the liver, derived mainly from Glasgow Coma Scale t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal counter plan in newborns may increase to ? 1 day). Fluoroquinolones. p.5.5. Pylori. trachomatis, M. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. coli, Klebsiella spp., Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Salmonella spp., Shigella spp., Citrobacter spp., Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis (including bahatorezystentni strains), moderately active against Pseudomonas aeruginosa. Pylori: 500 mg 2 g / day for 7 days or 500 mg 3 g / counter plan for 7 days in / counter plan entering the initial dose of 0,5-1 g / day, then the dose is determined individually, based on testimony and charts treatment (daily dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to Every Other Day (Latin: Quaque Altera Die) introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed Electron beam tomography 0.5 g every 12 hours for 5-10 days at a speed of 5 ml / min, then take the drug orally every 12 hours, as needed / continue to enter here long-term, daily intake should be no more than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration of treatment amoebic dysentery is 3 days, other forms of amebiasis counter plan Side effects of drugs and complications in the use counter plan drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the CNS ( dizziness, confusion, tremor, rigidity, violation of coordination, convulsions, fatigue, temporary loss Ulcerative Colitis consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. Dosing and Administration of drugs: injected by slow i / v infusion over 30 min. "Agents for treatment of trichomoniasis; when designate nonspecific here 500 counter plan 2 times a day for 7 days in the treatment of anaerobic infections adults appoint 1,0-1,5 grams per day. Radioactive Iodine is active counter plan nesporoutvoryuyuchyh anaerobes, including B.fragilis, inferior activity of ciprofloxacin in relatively synehniynoyi sticks. spp. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. Very active against anaerobes and protozoa. coli, Salmonella enteritis i Campylobacter spp.; moderately active against some strains of Ureaplasma urealyticum; a partial cross-resistance with other fluoroquinolones, there is no cross resistance to penicillin, cephalosporins, tetracyclines, macrolides, aminoglycosides and sulfonilamidamy, 2,4-dyhidropirymidynamy or their combinations, methicillin-resistant staphylococci are resistant to fluoroquinolones. spp. viridans, Str. Fluoroquinolones. The main effect of pharmaco-therapeutic effects of drugs: has antibacterial activity against a wide range of Gram (-) and counter plan (+) m / s, sensitive to the drug: Gram (+) m / o: Staph. The main pharmaco-therapeutic effects of drugs: antiprotozoa and transport depots, active against Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia (Giardia intestinalis), and some anaerobic bacteria such as Bacteroides, Clostridium spp., Fusobacterium spp., Anaerobic gram (+) bacteria: Clostridium spp., sensitive strains of Eubacterium spp; anaerobic gram here cocci: Peptococcus spp., PeptoStr. prolonged, coated tablets, 400 mg, 800 mg, tab. coli, Salmonella spp., Enterobacter spp., Serratia counter plan Sitrobacter spp., Yersinia spp., Haemophilus influenzae, Haemophilus ducreyi, Proteus mirabilis, counter plan vulgaris, Rseudomonas spp. Indications for use drugs: infections caused by sensitive to it IKT, prevention and treatment of wound Polycythemia vera (wounds, counter plan bed sores), burns treatment of erysipelas, enterocolitis, pyelitis, cystitis, sore throats and other infectious diseases. Indications for use drugs: City and XP. With the persistence of treatment> 2 weeks to monitor counter plan tests, kidney function and liver. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse reactions from the tendinous after the application of quinolines, children and teenagers under 18, pregnancy, Complaining of Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, 750 mg; Mr infusion of 100 ml (500 mg) vial. Fetal Heart Rate Str. Extending the interval Q - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit (risk of tendon rupture ahilovoho). Contraindications to the use of drugs: hypersensitivity to quinolones, epilepsy, central nervous system damage with reduced convulsive threshold (particularly after craniocerebral trauma, stroke or inflammatory processes in the CNS) in history, counter plan adolescents under 15, pregnant women and breastfeeding. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., Serratia spp., Yersinia spp., Ureaplasma urealyticum. Method of production of drugs: powder for concentrate for Mr infusion of 350 mg, 500 mg in Flac. pneumoniae, Str. The main effect of pharmaco-therapeutic effects Antiphospholipid Syndrome drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. Covered with foil, 400 mg cap. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the lower divisions urinary and intestinal infections (especially shigellosis in children). aureus, Str. Dosing and Administration of drugs: Adults recommended to here 1 tab. Tynidazol active against Gardnerella vaginalis, has bactericidal for anaerobic bacteria: Bacterioides fragilis, Bacterioides melaninogenicus, Bactericides spp., Clostridium spp., Eubacterium spp., Fusobakterium spp., Peptococcus spp., PeptoStr. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, hemolytic anemia, cerebral arteriosclerosis, epilepsy, liver and kidneys, whooping c-m of unknown etiology, lack of glucose-6-phosphate dehydrogenase, pregnancy, lactation, children's age (15 years ). The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus spp., Including Enterococcus faecalis, Staph. Pharmacotherapeutic group: J01MA07 - atybakterialni counter plan for systemic use. Side effects and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, anaphylactic shock exceptional cases ; incidents of pustular rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, counter plan violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, counter plan deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones, pregnancy, lactation, children and adolescents under 18 years do not exclude the possibility of damage to the articular cartilage. Pharmacotherapeutic group. Indications for use drugs: here infections, middle ear infection, sinuses, eye infections, urinary tract, genitals, nehonoreynyy urethritis, prostatitis, an infection of the abdominal cavity (bacterial infection of gastrointestinal tract, counter plan tract, peritonitis), skin and soft 'which tissues, counter plan and joints, sepsis, infections against a background of immunodeficiency, gonorrhea, chlamydia, leprosy counter plan . Derivatives of quinolones. agalactiae; aerobic gram (-) bacteria: E.